NIRTEK was formed to prevent heart attacks and save lives by detecting unstable coronary plaques using a patented technology known as Near Infra-Red Auto Fluorescence (NIRAF) so they can be treated before they lead to major adverse cardiovascular events, the leading cause of death worldwide.
Headquarter Australia |
Year founded 2020 (4 years) |
Funding status Private |
Company type SME |
Non Executive Director
Managing Director & CEO
Chief Technology Officer
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Non Executive Director | hidden.item | hidden.item | hidden.item | |||
Managing Director & CEO | hidden.item | hidden.item | hidden.item | |||
Chief Technology Officer | - | hidden.item | hidden.item | hidden.item |